These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17525728)

  • 1. Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS.
    Gondek LP; Tiu R; Haddad AS; O'Keefe CL; Sekeres MA; Theil KS; Maciejewski JP
    Leukemia; 2007 Sep; 21(9):2058-61. PubMed ID: 17525728
    [No Abstract]   [Full Text] [Related]  

  • 2. An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.
    Stahl M; Abdel-Wahab O; Wei AH; Savona MR; Xu ML; Xie Z; Taylor J; Starczynowski D; Sanz GF; Sallman DA; Santini V; Roboz GJ; Patnaik MM; Padron E; Odenike O; Nazha A; Nimer SD; Majeti R; Little RF; Gore S; List AF; Kutchroo V; Komrokji RS; Kim TK; Kim N; Hourigan CS; Hasserjian RP; Halene S; Griffiths EA; Greenberg PL; Figueroa M; Fenaux P; Efficace F; DeZern AE; Della Porta MG; Daver NG; Churpek JE; Carraway HE; Brunner AM; Borate U; Bennett JM; Bejar R; Boultwood J; Loghavi S; Bewersdorf JP; Platzbecker U; Steensma DP; Sekeres MA; Buckstein RJ; Zeidan AM
    Blood Adv; 2023 Jun; 7(12):2709-2714. PubMed ID: 36260702
    [No Abstract]   [Full Text] [Related]  

  • 3. Pitfalls of multi-species SNP arrays introducing new forms of ascertainment bias.
    Jighly A
    Plant Genome; 2024 Jun; 17(2):e20459. PubMed ID: 38785130
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
    Bahaj W; Kewan T; Gurnari C; Durmaz A; Ponvilawan B; Pandit I; Kubota Y; Ogbue OD; Zawit M; Madanat Y; Bat T; Balasubramanian SK; Awada H; Ahmed R; Mori M; Meggendorfer M; Haferlach T; Visconte V; Maciejewski JP
    J Hematol Oncol; 2023 Aug; 16(1):91. PubMed ID: 37537667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
    Arber DA; Orazi A; Hasserjian RP; Borowitz MJ; Calvo KR; Kvasnicka HM; Wang SA; Bagg A; Barbui T; Branford S; Bueso-Ramos CE; Cortes JE; Dal Cin P; DiNardo CD; Dombret H; Duncavage EJ; Ebert BL; Estey EH; Facchetti F; Foucar K; Gangat N; Gianelli U; Godley LA; Gökbuget N; Gotlib J; Hellström-Lindberg E; Hobbs GS; Hoffman R; Jabbour EJ; Kiladjian JJ; Larson RA; Le Beau MM; Loh ML; Löwenberg B; Macintyre E; Malcovati L; Mullighan CG; Niemeyer C; Odenike OM; Ogawa S; Orfao A; Papaemmanuil E; Passamonti F; Porkka K; Pui CH; Radich JP; Reiter A; Rozman M; Rudelius M; Savona MR; Schiffer CA; Schmitt-Graeff A; Shimamura A; Sierra J; Stock WA; Stone RM; Tallman MS; Thiele J; Tien HF; Tzankov A; Vannucchi AM; Vyas P; Wei AH; Weinberg OK; Wierzbowska A; Cazzola M; Döhner H; Tefferi A
    Blood; 2022 Sep; 140(11):1200-1228. PubMed ID: 35767897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
    Grob T; Al Hinai ASA; Sanders MA; Kavelaars FG; Rijken M; Gradowska PL; Biemond BJ; Breems DA; Maertens J; van Marwijk Kooy M; Pabst T; de Weerdt O; Ossenkoppele GJ; van de Loosdrecht AA; Huls GA; Cornelissen JJ; Beverloo HB; Löwenberg B; Jongen-Lavrencic M; Valk PJM
    Blood; 2022 Apr; 139(15):2347-2354. PubMed ID: 35108372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
    Bersanelli M; Travaglino E; Meggendorfer M; Matteuzzi T; Sala C; Mosca E; Chiereghin C; Di Nanni N; Gnocchi M; Zampini M; Rossi M; Maggioni G; Termanini A; Angelucci E; Bernardi M; Borin L; Bruno B; Bonifazi F; Santini V; Bacigalupo A; Voso MT; Oliva E; Riva M; Ubezio M; Morabito L; Campagna A; Saitta C; Savevski V; Giampieri E; Remondini D; Passamonti F; Ciceri F; Bolli N; Rambaldi A; Kern W; Kordasti S; Sole F; Palomo L; Sanz G; Santoro A; Platzbecker U; Fenaux P; Milanesi L; Haferlach T; Castellani G; Della Porta MG
    J Clin Oncol; 2021 Apr; 39(11):1223-1233. PubMed ID: 33539200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial.
    Burd A; Levine RL; Ruppert AS; Mims AS; Borate U; Stein EM; Patel P; Baer MR; Stock W; Deininger M; Blum W; Schiller G; Olin R; Litzow M; Foran J; Lin TL; Ball B; Boyiadzis M; Traer E; Odenike O; Arellano M; Walker A; Duong VH; Kovacsovics T; Collins R; Shoben AB; Heerema NA; Foster MC; Vergilio JA; Brennan T; Vietz C; Severson E; Miller M; Rosenberg L; Marcus S; Yocum A; Chen T; Stefanos M; Druker B; Byrd JC
    Nat Med; 2020 Dec; 26(12):1852-1858. PubMed ID: 33106665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
    Bernard E; Nannya Y; Hasserjian RP; Devlin SM; Tuechler H; Medina-Martinez JS; Yoshizato T; Shiozawa Y; Saiki R; Malcovati L; Levine MF; Arango JE; Zhou Y; Solé F; Cargo CA; Haase D; Creignou M; Germing U; Zhang Y; Gundem G; Sarian A; van de Loosdrecht AA; Jädersten M; Tobiasson M; Kosmider O; Follo MY; Thol F; Pinheiro RF; Santini V; Kotsianidis I; Boultwood J; Santos FPS; Schanz J; Kasahara S; Ishikawa T; Tsurumi H; Takaori-Kondo A; Kiguchi T; Polprasert C; Bennett JM; Klimek VM; Savona MR; Belickova M; Ganster C; Palomo L; Sanz G; Ades L; Della Porta MG; Elias HK; Smith AG; Werner Y; Patel M; Viale A; Vanness K; Neuberg DS; Stevenson KE; Menghrajani K; Bolton KL; Fenaux P; Pellagatti A; Platzbecker U; Heuser M; Valent P; Chiba S; Miyazaki Y; Finelli C; Voso MT; Shih LY; Fontenay M; Jansen JH; Cervera J; Atsuta Y; Gattermann N; Ebert BL; Bejar R; Greenberg PL; Cazzola M; Hellström-Lindberg E; Ogawa S; Papaemmanuil E
    Nat Med; 2020 Oct; 26(10):1549-1556. PubMed ID: 32747829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.
    Palomo L; Meggendorfer M; Hutter S; Twardziok S; Ademà V; Fuhrmann I; Fuster-Tormo F; Xicoy B; Zamora L; Acha P; Kerr CM; Kern W; Maciejewski JP; Solé F; Haferlach C; Haferlach T
    Blood; 2020 Oct; 136(16):1851-1862. PubMed ID: 32573691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway.
    Chen S; Wang Q; Yu H; Capitano ML; Vemula S; Nabinger SC; Gao R; Yao C; Kobayashi M; Geng Z; Fahey A; Henley D; Liu SZ; Barajas S; Cai W; Wolf ER; Ramdas B; Cai Z; Gao H; Luo N; Sun Y; Wong TN; Link DC; Liu Y; Boswell HS; Mayo LD; Huang G; Kapur R; Yoder MC; Broxmeyer HE; Gao Z; Liu Y
    Nat Commun; 2019 Dec; 10(1):5649. PubMed ID: 31827082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.
    Nagata Y; Makishima H; Kerr CM; Przychodzen BP; Aly M; Goyal A; Awada H; Asad MF; Kuzmanovic T; Suzuki H; Yoshizato T; Yoshida K; Chiba K; Tanaka H; Shiraishi Y; Miyano S; Mukherjee S; LaFramboise T; Nazha A; Sekeres MA; Radivoyevitch T; Haferlach T; Ogawa S; Maciejewski JP
    Nat Commun; 2019 Nov; 10(1):5386. PubMed ID: 31772163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis.
    Yan H; Qu J; Cao W; Liu Y; Zheng G; Zhang E; Cai Z
    Cancer Immunol Immunother; 2019 Dec; 68(12):1971-1978. PubMed ID: 31650199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dominant-negative effect drives selection of
    Boettcher S; Miller PG; Sharma R; McConkey M; Leventhal M; Krivtsov AV; Giacomelli AO; Wong W; Kim J; Chao S; Kurppa KJ; Yang X; Milenkowic K; Piccioni F; Root DE; Rücker FG; Flamand Y; Neuberg D; Lindsley RC; Jänne PA; Hahn WC; Jacks T; Döhner H; Armstrong SA; Ebert BL
    Science; 2019 Aug; 365(6453):599-604. PubMed ID: 31395785
    [No Abstract]   [Full Text] [Related]  

  • 15. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.
    Haase D; Stevenson KE; Neuberg D; Maciejewski JP; Nazha A; Sekeres MA; Ebert BL; Garcia-Manero G; Haferlach C; Haferlach T; Kern W; Ogawa S; Nagata Y; Yoshida K; Graubert TA; Walter MJ; List AF; Komrokji RS; Padron E; Sallman D; Papaemmanuil E; Campbell PJ; Savona MR; Seegmiller A; Adès L; Fenaux P; Shih LY; Bowen D; Groves MJ; Tauro S; Fontenay M; Kosmider O; Bar-Natan M; Steensma D; Stone R; Heuser M; Thol F; Cazzola M; Malcovati L; Karsan A; Ganster C; Hellström-Lindberg E; Boultwood J; Pellagatti A; Santini V; Quek L; Vyas P; Tüchler H; Greenberg PL; Bejar R;
    Leukemia; 2019 Jul; 33(7):1747-1758. PubMed ID: 30635634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional genomic landscape of acute myeloid leukaemia.
    Tyner JW; Tognon CE; Bottomly D; Wilmot B; Kurtz SE; Savage SL; Long N; Schultz AR; Traer E; Abel M; Agarwal A; Blucher A; Borate U; Bryant J; Burke R; Carlos A; Carpenter R; Carroll J; Chang BH; Coblentz C; d'Almeida A; Cook R; Danilov A; Dao KT; Degnin M; Devine D; Dibb J; Edwards DK; Eide CA; English I; Glover J; Henson R; Ho H; Jemal A; Johnson K; Johnson R; Junio B; Kaempf A; Leonard J; Lin C; Liu SQ; Lo P; Loriaux MM; Luty S; Macey T; MacManiman J; Martinez J; Mori M; Nelson D; Nichols C; Peters J; Ramsdill J; Rofelty A; Schuff R; Searles R; Segerdell E; Smith RL; Spurgeon SE; Sweeney T; Thapa A; Visser C; Wagner J; Watanabe-Smith K; Werth K; Wolf J; White L; Yates A; Zhang H; Cogle CR; Collins RH; Connolly DC; Deininger MW; Drusbosky L; Hourigan CS; Jordan CT; Kropf P; Lin TL; Martinez ME; Medeiros BC; Pallapati RR; Pollyea DA; Swords RT; Watts JM; Weir SJ; Wiest DL; Winters RM; McWeeney SK; Druker BJ
    Nature; 2018 Oct; 562(7728):526-531. PubMed ID: 30333627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of chronic myelomonocytic leukemia with TP53 mutations.
    Wang W; Routbort MJ; Loghavi S; Tang Z; Medeiros LJ; Wang SA
    Leuk Res; 2018 Jul; 70():97-99. PubMed ID: 29908419
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.
    Patnaik MM; Vallapureddy R; Yalniz FF; Hanson CA; Ketterling RP; Lasho TL; Finke C; Al-Kali A; Gangat N; Tefferi A
    Am J Hematol; 2018 Jan; 93(1):65-73. PubMed ID: 29023992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5 reveals a specific spectrum of molecular mutations with prognostic impact: a study on 123 patients and 27 genes.
    Meggendorfer M; Haferlach C; Kern W; Haferlach T
    Haematologica; 2017 Sep; 102(9):1502-1510. PubMed ID: 28642303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of clonal evolution in myelodysplastic syndromes.
    Makishima H; Yoshizato T; Yoshida K; Sekeres MA; Radivoyevitch T; Suzuki H; Przychodzen B; Nagata Y; Meggendorfer M; Sanada M; Okuno Y; Hirsch C; Kuzmanovic T; Sato Y; Sato-Otsubo A; LaFramboise T; Hosono N; Shiraishi Y; Chiba K; Haferlach C; Kern W; Tanaka H; Shiozawa Y; Gómez-Seguí I; Husseinzadeh HD; Thota S; Guinta KM; Dienes B; Nakamaki T; Miyawaki S; Saunthararajah Y; Chiba S; Miyano S; Shih LY; Haferlach T; Ogawa S; Maciejewski JP
    Nat Genet; 2017 Feb; 49(2):204-212. PubMed ID: 27992414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.